Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - azadirachtin(11.82g/l)+methomyl(225g/l)+chlorpyrifos(500g/l) + others - various

Israel - English - Ministry of Health

sanofi israel ltd - iron as iron iii sodium ferric glugonate compl. - solution for injection/ concentrate for solution for infusion - iron as iron iii sodium ferric glugonate compl. 62.5 mg / 5 ml - various combinations - various combinations - ferrlecit is indicated in adults and children 6 years and above.severe iron deficiency states only when oral administration has been found impossible; in cases of gastrointestinal malabsorption which rules out oral iron therapy; patients treated by dialysis getting erythropoietin.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 44040 - neural-tissue electrical stimulation lead - ans lamitrode s-series (s4 and s8) leads are indicated for the treatment of chronic pain of the trunk and limbs, either as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. lamitrode s-series leads are intended to be used with advanced neuromodulation system?s ipgs, receivers, transmitters, patient programmers, and extensions.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 44040 - neural-tissue electrical stimulation lead - ans lamitrode leads are indicated for the treatment of chronic pain of the trunk and limbs, either as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. lamitrode leads are intended to be used with advanced neuromodulation system's ipgs, receivers, transmitters, patient programmers, and extensions.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 44040 - neural-tissue electrical stimulation lead - ans lamitrode leads are indicated for the treatment of chronic pain of the trunk and limbs, either as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. lamitrode leads are intended to be used with advanced neuromodulation system's ipgs, receivers, transmitters, patient programmers, and extensions.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 44040 - neural-tissue electrical stimulation lead - ans lamitrode s-series (s4 and s8) leads are indicated for the treatment of chronic pain of the trunk and limbs, either as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. lamitrode s-series leads are intended to be used with advanced neuromodulation system?s ipgs, receivers, transmitters, patient programmers, and extensions.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 44040 - neural-tissue electrical stimulation lead - ans lamitrode leads are indicated for the treatment of chronic pain of the trunk and limbs, either as the sole mitigating agent, or as an adjunct to other modes of therapy used in a multidisciplinary approach. lamitrode leads are intended to be used with advanced neuromodulation system?s ipgs, receivers, transmitters, patient programmers, and extensions.

Australia - English - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - fluazinam(500g/l)+metosulam(100g/l)+ethofumesate(500g/l) + others - various

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - cu as oxychloride(500g/kg)+tebuconazole(430g/l)+2,4-d as ipa(300g/l) + others - various